CD4 and cancer: The ability of this vaccine to work in the absence of CD4+ T “helper” cells may be translationally important in the context of cancer patients (e.g., HIV-infected and some after chemotherapy) who are frequently deficient in (Type-1) CD4+ Th function.57,58